This Super Micro Computer Analyst Turns Bearish; Here Are Top 5 Upgrades For Wednesday
This Super Micro Computer Analyst Turns Bearish; Here Are Top 5 Upgrades For Wednesday
这位超微电脑分析师转为看淡;以下是周三的前5项升级
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
华尔街顶级分析师改变了对这些顶级公司的展望。如需查看包括升级和降级在内的所有分析师评级变化的完整视图,请参阅我们的分析师评级页面。
- Keybanc analyst Steve Barger downgraded the rating for Myers Industries, Inc. (NYSE:MYE) from Overweight to Sector Weight. Myers shares closed at $11.39 on Tuesday. See how other analysts view this stock.
- TD Cowen analyst Vivien Azer downgraded the rating for Brown-Forman Corporation (NYSE:BF) from Buy to Hold and lowered the price target from $50 to $48. Brown-Forman shares closed at $43.74 on Tuesday. See how other analysts view this stock.
- JP Morgan analyst Samik Chatterjee downgraded Super Micro Computer, Inc. (NASDAQ:SMCI) from Neutral to Underweight and slashed the price target from $50 to $23. Super Micro Computer shares closed at $27.70 on Tuesday. See how other analysts view this stock.
- B of A Securities analyst Kevin Fischbeck downgraded Ardent Health Partners, Inc. (NYSE:ARDT) from Buy to Neutral and lowered the price target from $22 to $19. Ardent Health Partners shares closed at $18.05 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Oren Livnat downgraded the rating for Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) from Buy to Neutral. Verrica Pharmaceuticals shares closed at $0.7975 on Tuesday. See how other analysts view this stock.
- Keybanc分析师Steve Barger将Myers Industries, Inc. (纽交所:MYE) 的评级由超买入调降至板块权重。Myers股价周二收于$11.39。查看其他分析师对这只股票的看法。
- TD Cowen分析师Vivien Azer将Brown-Forman Corporation (纽交所:BF) 的评级由买入调降至持有,并将价格目标从$50降至$48。Brown-Forman股价周二收于$43.74。查看其他分析师对这只股票的看法。
- JP Morgan分析师Samik Chatterjee将超微电脑, Inc. (纳斯达克:SMCI) 的评级由中立调降至低于市场表现,并将价格目标从$50调降至$23。超微电脑股价周二收于$27.70。查看其他分析师对这只股票的看法。
- b of A Securities分析师Kevin Fischbeck将Ardent Health Partners, Inc. (纽交所:ARDT) 的评级由买入调降至中立,并将价格目标从$22降至$19。Ardent Health Partners股价周二收于$18.05。查看其他分析师对这只股票的看法。
- HC Wainwright & Co.分析师Oren Livnat将verrica制药公司, Inc. (纳斯达克:VRCA) 的评级由买入调降至中立。verrica制药公司股价周二收于$0.7975。查看其他分析师对这只股票的看法。
Considering buying CHWY stock? Here's what analysts think:
考虑买入CHWY股票?以下是分析师的看法:
Read More:
阅读更多:
- Cramer Says He Can't Recommend This Major Automaker, Ceva Is 'Way Too High'
- 克雷默表示,他无法推荐这家主要的汽车制造商,Ceva股价太高。